{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1220"}, "official-title": {"#tail": "\n\t", "#text": "To direct the Administrator of the Environmental\n\t\t  Protection Agency to allow for the distribution, sale, and consumption in the\n\t\t  United States of remaining inventories of over-the-counter CFC epinephrine\n\t\t  inhalers."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130315", "#text": "March 15, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee\n\t\t\t on Energy and Commerce"}, "sponsor": {"#tail": " (for\n\t\t\t himself, ", "#text": "Mr. Burgess", "@name-id": "B001248"}, "cosponsor": [{"#tail": ", and\n\t\t\t ", "#text": "Mr. Dingell", "@name-id": "D000355"}, {"#tail": ") introduced the following\n\t\t\t bill; which was referred to the ", "#text": "Mr. Matheson", "@name-id": "M001142"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HDDE8AD359E264E17AF94D2D8F5BCA6C9", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Asthma Inhalers Relief Act of\n\t\t\t 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "HD48480C4CD1E4D6EAC8BAE0C29239C07"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Distribution,\n\t\t\t sale, and consumption of remaining inventories of over-the-counter CFC\n\t\t\t epinephrine inhalers"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Administrator of\n\t\t\t the Environmental Protection Agency", "@entity-id": "6800"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "shall allow for the distribution, sale, and\n\t\t\t consumption in the United States of remaining inventories of CFC epinephrine\n\t\t\t inhalers manufactured pursuant to the exception for medical devices under\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ";", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 604(d)(2) of the Clean Air Act", "@value": "Clean Air Act/s:604/ss:d/p:2"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 7671c(d)(2)", "@value": "usc/42/7671c/d/2"}, "@parsable-cite": "usc/42/7671c", "#text": "\n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H7333524E44364EE4BC4D7D49B2FE040B", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "shall not take any enforcement action or\n\t\t\t otherwise seek to restrict the distribution, sale, or consumption of such\n\t\t\t inhalers on the basis of any Federal law implementing the Montreal Protocol;\n\t\t\t and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H65B4F7FAA22E4BFEB18BFED40EA2D2A9", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " will not initiate an enforcement action relating to the\n\t\t\t distribution or sale of any such inhaler occurring prior to August 1,\n\t\t\t 2013.", "@entity-type": "federal-body", "#text": "Environmental\n\t\t\t Protection Agency", "@entity-id": "6800"}, "#text": "shall, in response\n\t\t\t to any request of any distributor or seller of such inhalers, including any\n\t\t\t such request pending on the date of the enactment of this Act, issue a No\n\t\t\t Action Assurance Letter to the requesting party stating that the "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "HC5E5817AED194AA7BFDB33B17568BC9B", "#text": "\n          "}], "#text": "\n        ", "@id": "HB19D5EC0206445CA8E2153776B73F9B0"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " under the ", "@entity-type": "federal-body", "#text": "Food\n\t\t\t and Drug Administration", "@entity-id": "7524"}, "#text": "Nothing in this\n\t\t\t Act shall be construed to limit or otherwise affect the authority of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " to ensure the safety and effectiveness of CFC epinephrine\n\t\t\t inhalers to be distributed, sold, or consumed pursuant to this Act.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21\n\t\t\t U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Rule of\n\t\t\t construction"}, "#text": "\n        ", "@id": "H3017DC8D05E14FBC884CC791E828F2D9"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "In\n\t\t\t this Act:"}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "term": {"#tail": " means any epinephrine inhaler containing\n\t\t\t chlo\u00adro\u00adfluo\u00adro\u00adcar\u00adbons that was manufactured and classified as\n\t\t\t over-the-counter before January 1, 2012.", "#text": "CFC epinephrine\n\t\t\t inhaler"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H406B4569BB1048EB8041E54DB37C1F6C", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "Federal law implementing the Montreal Protocol"}, "#text": "The phrase\n\t\t\t "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "#text": "\n          ", "@id": "H11FF120E449D4B0E85A5370FA0920D4A", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "means any provision of ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " or other Federal law implementing the\n\t\t\t Montreal Protocol; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "title VI of the\n\t\t\t Clean Air Act", "@value": "Clean Air Act/t:VI"}, "@entity-type": "law-citation", "#text": "\n                ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/42/7671", "#text": "42 U.S.C. 7671 et seq.", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H5E1D3A4D5E4F4586A6F2A4FF0DB021DD", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " entitled ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "term": {"#tail": " published in the\n\t\t\t Federal Register at 73 Federal Register 69532 (November 19, 2008).", "#text": "Use of Ozone-Depleting Substances;\n\t\t\t Removal of Essential-Use Designation (Epinephrine)"}, "#text": "includes the final rule published by the\n\t\t\t ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H81F0E7C4DC9B4B20BC0366BC1B96F25A", "#text": "\n            "}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "term": {"#tail": " has the meaning given such term in ", "#text": "Montreal Protocol"}, "#text": "The term\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 601\n\t\t\t of the Clean Air Act", "@value": "Clean Air Act/s:601"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "@parsable-cite": "usc/42/7671", "#text": "42 U.S.C. 7671", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H40E3D620CF334981BF5502E95C6238D8", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "term": {"#tail": " means not subject to ", "#text": "over-the-counter"}, "#text": "The term\n\t\t\t ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " or otherwise\n\t\t\t required pursuant to Federal law to be dispensed only upon issuance of a\n\t\t\t prescription.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 503(b)(1) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "21 U.S.C. 353(b)(1)", "@value": "usc/21/353/b/1"}, "@parsable-cite": "usc/21/353", "#text": "\n                ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H35CBD98D75B24BCA9D12C4FD2DBC1623", "#text": "\n          "}], "#text": "\n        ", "@id": "H9E21F4305A184B80BD0C031FDF8EDCE3"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "This\n\t\t\t section ceases to be effective August 1, 2013."}, "enum": {"#tail": "\n        ", "#text": "(d)"}, "header": {"#tail": "\n        ", "#text": "Sunset"}, "#text": "\n        ", "@id": "H0C159E5ED07140DB84EC44EF2F6DED8D"}], "#text": "\n      ", "@id": "HBE0800C1DD4C4CA688F58D0180F2994B"}], "#text": "\n\t\t", "@id": "H75368B46CAE748E59766D1EB5DB43708"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-15"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1220 IH: Asthma Inhalers Relief Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}